Conference abstractPublished 15 Nov 2021
My long experience in regenerative medicine
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Regenerative cell therapies may present multiple advantages to clinicians and patients who are looking to improve patient outcomes. These advantages could be obtained through multiple therapeutic modules, Since I started this type of treatment on 2006 by injecting PRP directly where it was needed then Gradually started to widen the scope of such therapy by injecting bone marrow extract which also gave as good results as the PRP. Gradually in 2014 we started to add to such treatment the purified Fat extract and in my experience add a wider scope for the treating conditions as well as a far better results from the PRP finally for the last few years also added the stem cells therapy extracted from the fat tissue which also added a valuable and effective treatment for managing a lot musculoskeletal cases. In addition to the effective treatment and good results actually, there is a significantly reduced risk of rejection or immune response using autologous biologics as compared to alternative treatment options. Also, there is minimal risk of allergic reactions or tissue rejection. Autologous regenerative therapy uses the normal regeneration and repair processes of the human body. From my long experience, I would like to emphasize that Patients or conditions that are most likely to respond to autologous, biologic-based products have not yet been internationally characterized. Therefore, clinical success depends on several factors including diagnosis, the severity of the condition being treated, patient age and comorbidities. I will go through this talk in presenting a journey explaining my clinical experience, the way I use and manage regenerative therapy, and the success that I achieved during this journey.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Stem Cell Biology and Transplantation
- SubjectGenetics & Molecular Biology
- SubjectSurgery
- BylineArticles whose byline prints “Issam Mardini”
